1. Pathophysiological changes in experimental polycystic ovary syndrome in female albino rats: Using either hemin or L -arginine
    Merhan M. Ragy et al, 2018, J Cell Physiol CrossRef
  2. Functional and endocrine-metabolic oligomenorrhea: proposal of a new diagnostic assessment tool for differential diagnosis in adolescence
    Silvia Baggio et al, 2019 CrossRef
  3. Association of Luteinizing hormone and LH receptor gene polymorphism with susceptibility of Polycystic ovary syndrome
    Ritu Deswal et al, 2019, Systems Biology in Reproductive Medicine CrossRef
  4. Very low dose spironolactone protects experimentally-induced polycystic ovarian syndrome from insulin-resistant metabolic disturbances by suppressing elevated circulating testosterone
    Oluwaseun A. Adeyanju et al, 2019, Chemico-Biological Interactions CrossRef
  5. Letrozole treatment of pubertal female mice results in activational effects on reproduction, metabolism and the gut microbiome
    Pablo Arroyo et al, 2019, PLoS ONE CrossRef
  6. Insulin Therapy in Pregnancy Hypertensive Diseases and its Effect on the Offspring and Mother Later in Life
    Alfonso Mate et al, 2019, CVP CrossRef
  7. Synergistic Effects of Hyperandrogenemia and Obesogenic Western-style Diet on Transcription and DNA Methylation in Visceral Adipose Tissue of Nonhuman Primates
    Lucia Carbone et al, 2019, Sci Rep CrossRef
  8. Emerging role of GIP and related gut hormones in fertility and PCOS
    R. Charlotte Moffett et al, 2020, Peptides CrossRef
  9. Proteomic sift through serum and endometrium profiles unraveled signature proteins associated with subdued fertility and dampened endometrial receptivity in women with polycystic ovary syndrome
    Nadia Rashid et al, 2020, Cell Tissue Res CrossRef
  10. Polycystic Ovary Syndrome and Pelvic Floor Dysfunction: A Narrative Review

    Marzieh Saei Ghare Naz et al, 2020, RRU CrossRef
  11. Relevance of KISS1 gene polymorphisms in susceptibility to polycystic ovary syndrome and its associated endocrine and metabolic disturbances
    MH Daghestani et al, 2020, British Journal of Biomedical Science CrossRef
  12. Prevalence of PCOD in Patients Visiting OPD of Karuna Medical College
    Harrini K et al, 2020, jemds CrossRef
  13. Correlation Between Fecal Metabolomics and Gut Microbiota in Obesity and Polycystic Ovary Syndrome
    Ling Zhou et al, 2020, Front. Endocrinol. CrossRef
  14. Individual and combined effects of 5-year exposure to hyperandrogenemia and Western-style diet on metabolism and reproduction in female rhesus macaques
    Cecily V Bishop et al, 2020 CrossRef
    I. I. Dedov et al, 2021, Obes. metabol. CrossRef
  16. The Ameliorating Effects of Bushen Huatan Granules and Kunling Wan on Polycystic Ovary Syndrome Induced by Dehydroepiandrosterone in Rats
    Yang Xu et al, 2021, Front. Physiol. CrossRef
  17. Effect of healthy lifestyle promotion on anthropometric variables, eating behavior and cardiometabolic risk factors in women with polycystic ovarian syndrome
    Latifa Imen Benharrat et al, 2020, Nor. Afr. J. Food Nutr. Res. CrossRef
  18. Recent updates on animal models for understanding the etiopathogenesis of polycystic ovarian syndrome
    Leander Corrie et al, 2021, Life Sciences CrossRef
  19. Autophagy in ovary and polycystic ovary syndrome: role, dispute and future perspective
    Sanjana Kumariya et al, 2021, Autophagy CrossRef
  20. Development and Evaluation of Curcumin Encapsulated Self-assembled Nanoparticles as Potential Remedial Treatment for PCOS in a Female Rat Model
    Mazhar Ali Raja et al, 2021, IJN CrossRef
  21. Long-Term Metabolic Consequences in Patients with a History of Gestational Diabetes
    Eleni Kousta et al, 2020, CPD CrossRef
  22. Predictive Value of Homeostasis Model Assessment of Insulin Resistance, Visceral Fat Index, and Prepregnancy Body Mass Index in Gestational Metabolic Syndrome
    Laiping Zhao et al, 2021, Evidence-Based Complementary and Alternative Medicine CrossRef
  23. Omega-3 supplementation in the treatment of polycystic ovary syndrome (PCOS) – a review of clinical trials and cohort
    Vitoria Melo et al, 2022 CrossRef
  24. Mogroside V Improves Follicular Development and Ovulation in Young-Adult PCOS Rats Induced by Letrozole and High-Fat Diet Through Promoting Glycolysis
    Lan’e Huang et al, 2022, Front. Endocrinol. CrossRef
  25. Circulating Microparticles as Indicators of Cardiometabolic Risk in PCOS
    Banafsheh Yalameha et al, 2022, Clinica Chimica Acta CrossRef
  26. Metagenomic analysis identified microbiome alterations and pathological association between intestinal microbiota and polycystic ovary syndrome
    Weiwei Chu et al, 2020, Fertility and Sterility CrossRef
  27. Exploration of hub genes involved in PCOS using biological informatics methods
    Fei Zhou et al, 2022 CrossRef
  28. The Implication of Mechanistic Approaches and the Role of the Microbiome in Polycystic Ovary Syndrome (PCOS): A Review
    Anirban Goutam Mukherjee et al, 2023, Metabolites CrossRef
  29. Association of Pregnancy Outcome Complications Among Females with Polycystic Ovary Syndrome
    Laiba Tariq et al, 2022, DF CrossRef
  30. Low-dose spironolactone attenuates metabolic defects in the skeletal muscle of letrozole-induced hyperandrogenic female rats
    Stephanie E. Areloegbe et al, 2023, Nutrire CrossRef
  31. Hyperandrogenism drives ovarian inflammation and pyroptosis: A possible pathogenesis of PCOS follicular dysplasia
    Yu Xiang et al, 2023, International Immunopharmacology CrossRef
  32. Prevalence and Dietary Management of Polycystic Ovary Syndrome among Libyan Women Attending in Infertility Center Tripoli, Libya
    Noor AL-Hoda Ben-Issa et al, 2024, Alq J Med App Sci CrossRef
  33. null
    Mohd Ashraf Ganie et al, 2024 CrossRef